DE69714024D1 - 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carbonsaure-derivate als endothelin-antagonisten - Google Patents

4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carbonsaure-derivate als endothelin-antagonisten

Info

Publication number
DE69714024D1
DE69714024D1 DE69714024T DE69714024T DE69714024D1 DE 69714024 D1 DE69714024 D1 DE 69714024D1 DE 69714024 T DE69714024 T DE 69714024T DE 69714024 T DE69714024 T DE 69714024T DE 69714024 D1 DE69714024 D1 DE 69714024D1
Authority
DE
Germany
Prior art keywords
dioxolyl
pyrrolidin
benzo
acid derivatives
carbonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69714024T
Other languages
English (en)
Other versions
DE69714024T2 (de
Inventor
S Tasker
A Boyd
K Sorensen
Martin Winn
Hwan-Soo Jae
Geldern W Von
J Henry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69714024D1 publication Critical patent/DE69714024D1/de
Publication of DE69714024T2 publication Critical patent/DE69714024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69714024T 1996-02-13 1997-02-10 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carbonsaure-derivate als endothelin-antagonisten Expired - Lifetime DE69714024T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60072496A 1996-02-13 1996-02-13
US79450597A 1997-02-04 1997-02-04
PCT/US1997/002128 WO1997030046A1 (en) 1996-02-13 1997-02-10 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists

Publications (2)

Publication Number Publication Date
DE69714024D1 true DE69714024D1 (de) 2002-08-22
DE69714024T2 DE69714024T2 (de) 2003-03-20

Family

ID=27083691

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69714024T Expired - Lifetime DE69714024T2 (de) 1996-02-13 1997-02-10 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carbonsaure-derivate als endothelin-antagonisten

Country Status (18)

Country Link
EP (1) EP0888340B1 (de)
JP (1) JP2000504727A (de)
CN (1) CN1079397C (de)
AR (1) AR005801A1 (de)
AT (1) ATE220673T1 (de)
AU (1) AU714597B2 (de)
BR (1) BR9707394A (de)
CA (1) CA2245684A1 (de)
CZ (1) CZ253698A3 (de)
DE (1) DE69714024T2 (de)
DK (1) DK0888340T3 (de)
ES (1) ES2182029T3 (de)
HU (1) HUP9902316A3 (de)
IL (1) IL125453A0 (de)
NZ (2) NZ331124A (de)
PT (1) PT888340E (de)
WO (1) WO1997030046A1 (de)
ZA (1) ZA971184B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208517B1 (en) 1994-08-19 2007-04-24 Abbott Labortories Endothelin antagonists
US6162927A (en) 1994-08-19 2000-12-19 Abbott Laboratories Endothelin antagonists
US6124341A (en) * 1996-02-13 2000-09-26 Abbott Laboratories Endothelin antagonists
HUP0002681A3 (en) * 1997-06-17 2001-09-28 Abbott Lab Pyrrolidine carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing the same
TR200101234T2 (tr) * 1997-08-04 2002-06-21 Abbott Laboratories Endotelin antagonistleri.
WO2002008185A1 (en) * 2000-07-19 2002-01-31 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as metalloprotease inhibitors
WO2002017912A1 (en) * 2000-08-31 2002-03-07 Abbott Laboratories Endothelin antagonists
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125980C1 (ru) * 1991-11-05 1999-02-10 Смитклайн Бичам Корпорейшн Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
WO1994002474A1 (en) * 1992-07-17 1994-02-03 Smithkline Beecham Corporation Endothelin receptor antagonists
CA2517691A1 (en) * 1994-08-19 1996-02-29 Abbott Laboratories Endothelin antagonists

Also Published As

Publication number Publication date
AU2267897A (en) 1997-09-02
HUP9902316A3 (en) 2001-12-28
ES2182029T3 (es) 2003-03-01
DE69714024T2 (de) 2003-03-20
AR005801A1 (es) 1999-07-14
BR9707394A (pt) 1999-04-06
CN1079397C (zh) 2002-02-20
NZ331124A (en) 2000-05-26
CZ253698A3 (cs) 1999-03-17
AU714597B2 (en) 2000-01-06
HUP9902316A2 (hu) 1999-11-29
ATE220673T1 (de) 2002-08-15
NZ503383A (en) 2002-02-01
PT888340E (pt) 2002-12-31
CA2245684A1 (en) 1997-08-21
EP0888340A1 (de) 1999-01-07
WO1997030046A1 (en) 1997-08-21
CN1215401A (zh) 1999-04-28
DK0888340T3 (da) 2002-11-04
EP0888340B1 (de) 2002-07-17
IL125453A0 (en) 1999-03-12
JP2000504727A (ja) 2000-04-18
ZA971184B (en) 1997-08-27

Similar Documents

Publication Publication Date Title
DE69531331D1 (de) Phenylpiperidinderivate als neurokinin antagonists
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
TR199700464A3 (tr) Antihistaminik etkili yeni benzimidazole türevleri.
NO970501D0 (no) Substituerte kinazolinderivater
DE69735710D1 (de) Neue benzo-1,3-dioxolyl-und benzofuranyl substituierte pyrrolidinederivate als endothelin antagonisten
DE69626220T2 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
DE69718786T2 (de) Benzoxazinone als dopamine -d4- rezeptor-antagonisten
ATE254621T1 (de) Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten
ATE240954T1 (de) Oxazolidinone als 5-ht2a-antagonisten
DE69714024T2 (de) 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carbonsaure-derivate als endothelin-antagonisten
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
NO992976L (no) Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
DE69714019T2 (de) 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten
HK1019328A1 (en) 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
ES1042140Y (es) Paraguas perfeccionado.
ES1037034Y (es) Barandilla perfeccionada.
ES1035984Y (es) Sombrilla de cabeza perfeccionada.
ES1033961Y (es) Sombrilla perfeccionada.
ES1042593Y (es) Sombrilla perfeccionada.
ES1039785Y (es) Sombrilla perfeccionada.
KR970049746U (ko) 아파트 베란다용 난간대

Legal Events

Date Code Title Description
8364 No opposition during term of opposition